Genetics on Early Onset Inflammatory Bowel Disease: An Update

Overview

Journal Genes Dis

Date 2020 Mar 18

PMID 32181280

Citations 12

Authors

Johnson Nameirakpam

Rashmi Rikhi

Sanjay Singh Rawat

Jyoti Sharma

Deepti Suri

Affiliations

Soon will be listed here.

Abstract

Inflammatory bowel disease (IBD) is more common in adults than in children. Onset of IBD before 17 years of age is referred as pediatric onset IBD and is further categorized as very early onset IBD (VEO-IBD) for children who are diagnosed before 6 years of age, infantile IBD who had the disease before 2 years of age and neonatal onset IBD for children less than 28 days of life. Children presenting with early onset disease may have a monogenic basis. Knowledge and awareness of the clinical manifestations facilitates early evaluation and diagnosis. Next generation sequencing is helpful in making the genetic diagnosis. Treatment of childhood IBD is difficult; targeted therapies and hematopoietic stem cell transplantation form the mainstay. In this review we aim to summarize the genetic defects associated with IBD phenotype. We describe genetic location and functions of various genetic defect associated with VEO-IBD with their key clinical manifestations. We also provide clinical clues to suspect these conditions and approaches to the diagnosis of these disorders and suitable treatment options.

Citing Articles

Influence of biological sex in inflammatory bowel diseases.

Tshikudi D, Bernstein C, Mishra S, Ghia J, Armstrong H Nat Rev Gastroenterol Hepatol. 2025; .

PMID: 39962330 DOI: 10.1038/s41575-025-01038-y.

MYO5B gene mutations may promote the occurrence of very early onset inflammatory bowel disease: a case report.

Lou Y, Lv Y, Yu J, Gu W, Jiang M, Chen J BMC Med Genomics. 2024; 17(1):187.

PMID: 39014344 PMC: 11250955. DOI: 10.1186/s12920-024-01962-z.

Very-early-onset Inflammatory Bowel Disease in an Infant with a Partial RIPK1 Deletion.

Tuna Kirsaclioglu C, Frohne A, Kuloglu Z, Kristofersdottir I, Demir E, Altuntas C J Clin Immunol. 2024; 44(5):108.

PMID: 38676845 PMC: 11055784. DOI: 10.1007/s10875-024-01707-8.

Intestinal Epithelial Cell-Related Alternative Splicing Events in Dextran Sodium Sulfate-Induced Acute Colitis.

Turk J Gastroenterol. 2023; 34(5):490-496.

PMID: 37158534 PMC: 10334696. DOI: 10.5152/tjg.2023.22572.

Hematopoietic stem cell Transplantation in Children with very Early Onset Inflammatory Bowel Disease Secondary to Monogenic Disorders of immune-dysregulation.

Meena S, Varla H, Swaminathan V, Chandar R, Jayakumar I, Ramakrishnan B Indian J Hematol Blood Transfus. 2023; 39(2):183-190.

PMID: 37006985 PMC: 10064404. DOI: 10.1007/s12288-022-01586-2.

References

Grieci T, Butter A . The incidence of inflammatory bowel disease in the pediatric population of Southwestern Ontario. J Pediatr Surg. 2009; 44(5):977-80. DOI: 10.1016/j.jpedsurg.2009.01.038. View

Uhlig H, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A . The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014; 147(5):990-1007.e3. PMC: 5376484. DOI: 10.1053/j.gastro.2014.07.023. View

Lopez-Herrera G, Tampella G, Pan-Hammarstrom Q, Herholz P, Trujillo-Vargas C, Phadwal K . Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet. 2012; 90(6):986-1001. PMC: 3370280. DOI: 10.1016/j.ajhg.2012.04.015. View

Neven B, Mamessier E, Bruneau J, Kaltenbach S, Kotlarz D, Suarez F . A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency. Blood. 2013; 122(23):3713-22. DOI: 10.1182/blood-2013-06-508267. View

Cannioto Z, Berti I, Martelossi S, Bruno I, Giurici N, Crovella S . IBD and IBD mimicking enterocolitis in children younger than 2 years of age. Eur J Pediatr. 2008; 168(2):149-55. DOI: 10.1007/s00431-008-0721-2. View

Kotlarz D, Marquardt B, Baroy T, Lee W, Konnikova L, Hollizeck S . Human TGF-β1 deficiency causes severe inflammatory bowel disease and encephalopathy. Nat Genet. 2018; 50(3):344-348. PMC: 6309869. DOI: 10.1038/s41588-018-0063-6. View

Glocker E, Frede N, Perro M, Sebire N, Elawad M, Shah N . Infant colitis--it's in the genes. Lancet. 2010; 376(9748):1272. DOI: 10.1016/S0140-6736(10)61008-2. View

Kucuk Z, Bleesing J, Marsh R, Zhang K, Davies S, Filipovich A . A challenging undertaking: Stem cell transplantation for immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. J Allergy Clin Immunol. 2015; 137(3):953-5.e4. DOI: 10.1016/j.jaci.2015.09.030. View

Engelhardt K, Shah N, Faizura-Yeop I, Uygun D, Frede N, Muise A . Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2012; 131(3):825-30. DOI: 10.1016/j.jaci.2012.09.025. View

10.

Jostins L, Ripke S, Weersma R, Duerr R, McGovern D, Hui K . Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012; 491(7422):119-24. PMC: 3491803. DOI: 10.1038/nature11582. View

11.

Dagata I, Paradis K, Chad Z, Bonny Y, Seidman E . Leucocyte adhesion deficiency presenting as a chronic ileocolitis. Gut. 1996; 39(4):605-8. PMC: 1383277. DOI: 10.1136/gut.39.4.605. View

12.

Hacein-Bey Abina S, Gaspar H, Blondeau J, Caccavelli L, Charrier S, Buckland K . Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome. JAMA. 2015; 313(15):1550-63. PMC: 4942841. DOI: 10.1001/jama.2015.3253. View

13.

Battaglia M, Stabilini A, Tresoldi E . Expanding human T regulatory cells with the mTOR-inhibitor rapamycin. Methods Mol Biol. 2011; 821:279-93. DOI: 10.1007/978-1-61779-430-8_17. View

14.

Yamaguchi T, Ihara K, Matsumoto T, Tsutsumi Y, Nomura A, Ohga S . Inflammatory bowel disease-like colitis in glycogen storage disease type 1b. Inflamm Bowel Dis. 2001; 7(2):128-32. DOI: 10.1097/00054725-200105000-00008. View

15.

Hanson E, Monaco-Shawver L, Solt L, Madge L, Banerjee P, May M . Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol. 2008; 122(6):1169-1177.e16. PMC: 2710968. DOI: 10.1016/j.jaci.2008.08.018. View

16.

Rohr J, Pannicke U, Doring M, Schmitt-Graeff A, Wiech E, Busch A . Chronic inflammatory bowel disease as key manifestation of atypical ARTEMIS deficiency. J Clin Immunol. 2009; 30(2):314-20. DOI: 10.1007/s10875-009-9349-x. View

17.

Chen R, Giliani S, Lanzi G, Mias G, Lonardi S, Dobbs K . Whole-exome sequencing identifies tetratricopeptide repeat domain 7A (TTC7A) mutations for combined immunodeficiency with intestinal atresias. J Allergy Clin Immunol. 2013; 132(3):656-664.e17. PMC: 3759618. DOI: 10.1016/j.jaci.2013.06.013. View

18.

Loftus Jr E . Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004; 126(6):1504-17. DOI: 10.1053/j.gastro.2004.01.063. View

19.

Cuchet-Lourenco D, Eletto D, Wu C, Plagnol V, Papapietro O, Curtis J . Biallelic mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation. Science. 2018; 361(6404):810-813. PMC: 6529353. DOI: 10.1126/science.aar2641. View

20.

Uzel G, Sampaio E, Lawrence M, Hsu A, Hackett M, Dorsey M . Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome. J Allergy Clin Immunol. 2013; 131(6):1611-23. PMC: 3672257. DOI: 10.1016/j.jaci.2012.11.054. View